Several decades of research continue to show that activity-dependent changes in synaptic efficacy are critical to experience-dependent modification of neural function. The mechanisms underlying these changes are more diverse than previously expected. Recently, a new type of use-dependent synaptic plasticity that requires retrograde signaling by endogenous cannabinoids (endocannabinoids) has been identified in several brain structures. Endocannabinoids are produced "on-demand" from neurons, cross the synaptic cleft, and by activating presynaptic cannabinoid receptors, suppress transmitter release in a transient or long-term manner. The mechanisms and physiological consequences of endocannabinoid-mediated synaptic plasticity are not fully understood. The experiments proposed here are designed to investigate the molecular mechanisms downstream of cannabinoid receptor activation, induction rules under more physiological conditions, and functional impact of eCB-mediated synaptic plasticity. To address these issues, we will focus on the hippocampus in vitro where we have found that endocannabinoids mediate long-term depression at inhibitory synapses. We will also extend our studies of eCB-plasticity to the dentate gyrus and prefrontal cortex, two brain areas where eCBs are thought to play a role in the etiology of epilepsy and schizophrenia, respectively. By modulating synaptic transmission, endocannabinoids participate in a wide range of brain function including cognition, motor control, aversive and feeding behaviors, pain perception and reward. Dysregulation of endocannabinoid signaling has been implicated in several neurological and psychiatric conditions. A better understanding of endocannabinoid-mediated plasticity is crucial not only a more realistic representation of neural function but also to identify how marijuana abuse may affect the brain, and ultimately, to develop novel therapeutic strategies targeting the endocannabinoid system.

Public Health Relevance

Endocannabinoids have emerged as key regulators of basic neural functions by mediating activity-dependent synaptic plasticity. Drugs that target these molecules and their receptors could be extremely useful for the development of new treatments for a variety of neurological and psychiatric disorders. Research on the endocannabinoid system not only helps in gaining a greater understanding of how marijuana acts in the brain and why it is abused, but it also provides new clues about how the brain works.

Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Research Project (R01)
Project #
5R01DA017392-10
Application #
8387030
Study Section
Neurotransporters, Receptors, and Calcium Signaling Study Section (NTRC)
Program Officer
Sorensen, Roger
Project Start
2003-08-01
Project End
2014-11-30
Budget Start
2012-12-01
Budget End
2014-11-30
Support Year
10
Fiscal Year
2013
Total Cost
$306,067
Indirect Cost
$121,689
Name
Albert Einstein College of Medicine
Department
Neurosciences
Type
Schools of Medicine
DUNS #
110521739
City
Bronx
State
NY
Country
United States
Zip Code
10461
Hou, Hailong; Chávez, Andrés E; Wang, Chih-Chieh et al. (2014) The Rac1 inhibitor NSC23766 suppresses CREB signaling by targeting NMDA receptor function. J Neurosci 34:14006-12
Vargas, Karina J; Makani, Sachin; Davis, Taylor et al. (2014) Synucleins regulate the kinetics of synaptic vesicle endocytosis. J Neurosci 34:9364-76
Younts, Thomas J; Castillo, Pablo E (2014) Endogenous cannabinoid signaling at inhibitory interneurons. Curr Opin Neurobiol 26:42-50
Kaeser-Woo, Yea Jin; Younts, Thomas J; Yang, Xiaofei et al. (2013) Synaptotagmin-12 phosphorylation by cAMP-dependent protein kinase is essential for hippocampal mossy fiber LTP. J Neurosci 33:9769-80
Younts, Thomas J; Chevaleyre, Vivien; Castillo, Pablo E (2013) CA1 pyramidal cell theta-burst firing triggers endocannabinoid-mediated long-term depression at both somatic and dendritic inhibitory synapses. J Neurosci 33:13743-57
Hunt, David L; Puente, Nagore; Grandes, Pedro et al. (2013) Bidirectional NMDA receptor plasticity controls CA3 output and heterosynaptic metaplasticity. Nat Neurosci 16:1049-59
Klein, Matthew E; Younts, Thomas J; Castillo, Pablo E et al. (2013) RNA-binding protein Sam68 controls synapse number and local ?-actin mRNA metabolism in dendrites. Proc Natl Acad Sci U S A 110:3125-30
Tsetsenis, Theodoros; Younts, Thomas J; Chiu, Chiayu Q et al. (2011) Rab3B protein is required for long-term depression of hippocampal inhibitory synapses and for normal reversal learning. Proc Natl Acad Sci U S A 108:14300-5
Chiu, Chiayu Q; Puente, Nagore; Grandes, Pedro et al. (2010) Dopaminergic modulation of endocannabinoid-mediated plasticity at GABAergic synapses in the prefrontal cortex. J Neurosci 30:7236-48
Kaeser, Pascal S; Deng, Lunbin; Chavez, Andres E et al. (2009) ELKS2alpha/CAST deletion selectively increases neurotransmitter release at inhibitory synapses. Neuron 64:227-39

Showing the most recent 10 out of 16 publications